CareDx

CareDx Q1 Revenues up 18 Percent

In Brief This Week: Castle Biosciences, Roche, Biocept, Ellume, Accelerate Diagnostics, and More

Jury Awards CareDx $44.9M in Natera Lawsuit; Finds Both Companies Engaged in False Advertising

CareDx Q4 Revenues Rise 35 Percent

CareDx, Castle Bio, Lucira Health, Others Announce Preliminary Q4, FY21 Earnings Results

CareDx to Study AlloSure Kidney for Routine Organ Transplant Surveillance in Pediatric Patients

In Brief This Week: PerkinElmer, Labcorp, Illumina, Thermo Fisher Scientific, and More

In Brief This Week: MDxHealth, Co-Diagnostics, HTG Molecular Diagnostics, Immunovia, and More

Broader Markets Lift 360Dx Index 3 Percent in October

CareDx Q3 Revenues Grow 42 Percent; Firm Discloses Investigations by DOJ, SEC

In Brief This Week: Quanterix, Cue Health, Hologic, CareDx, and More

Broader Markets Weigh Down Dx Stocks, 360Dx Index Falls 4 Percent in September

CareDx Patents Deemed Invalid in Court Battle Against Natera, Eurofins Viracor

360Dx Index Maintains Steady Ascent, Increasing 3 Percent in August

CareDx Q2 Revenues up 77 Percent

CareDx Q1 Revenues up 76 Percent

Bucking Downward 2021 Trend, 360Dx Index Rebounds 4 Percent in April